Consolidated Planning Corp Stryker Corp Transaction History

Consolidated Planning Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$324.3 - $354.67 $23,998 - $26,245	74 Added 7.72%	1,032 $351,000
Q1 2024 May 02, 2024	BUY	$293.94 - $358.71 $80,245 - $97,927	273 Added 39.85%	958 $342,000
Q4 2023 Feb 02, 2024	BUY	$253.85 - $299.46 $173,887 - $205,130	685 New	685 $205,000
Q4 2021 Feb 11, 2022	SELL	$236.63 - $276.44 $1,656 - $1,935	-7 Closed	0 $0
Q3 2021 Nov 17, 2021	BUY	$248.9 - $280.09 $1,742 - $1,960	7 New	7 $2,000

2,230

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $147B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Consolidated Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Consolidated Planning Corp with notifications on news.